• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Edgewise to Show Sevasemten Data for Becker, Duchenne Dystrophy

    PR NEWSWIRE

    Edgewise Therapeutics Reports Q2 2025 Financials and Business

    PR NEWSWIRE

    Edgewise Gets EMA Orphan Designation for Muscular Dystrophies Drug

    BUSINESSWIRE

    Edgewise Positive 2-Year Becker Sevasemten Topline Data

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.